Publications related to Tami Mark
Use of quality measures for Medicaid behavioral health services by state agencies: Implications for health care reform
Objective: The structure-process-outcome quality framework espoused by Donabedian provides a conceptual way to examine and prioritize behavioral health quality measures used by states. This report presents an environmental scan of the quality...
Current and Future Funding Sources for Specialty Mental Health and Substance Abuse Treatment Providers
As full implementation of the Affordable Care Act approaches, researchers are analyzing available data to reduce uncertainty about the future and help measure the effects of anticipated changes. This analysis of 1985–2005 data provides a baseline...
Understanding US addiction physicians' low rate of naltrexone prescription
Naltrexone was approved by the US Food and Drug Administration (FDA) in December 1994. Although it is one of only two medications for alcohol rehabilitation approved in the US, naltrexone is not frequently prescribed. This paper examines the...
Advancing performance measures for use of medications in substance abuse treatment.
Performance measures have the potential to drive high quality health care. However, technical and policy challenges exist in developing and implementing measures to assess substance use disorder (SUD) pharmacotherapy. Of critical importance in...
Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients
RESEARCH OBJECTIVE: The goal of this study was to examine prescription fill patterns of lipid-lowering agents among Medicare/ Medicaid dual-eligible patients by ethnicity. DATA AND METHODS: Study data were obtained from the Thomson Medstat...
Cost-effectiveness of preventing depression among at-risk youths
OBJECTIVE:: Youth depression can be prevented, yet few programs are offered. Decision makers lack cost information. This study evaluated the cost-effectiveness of a cognitive-behavioral prevention program (CBP) versus usual care. METHODS...
National Estimates of Behavioral Health Conditions and Their Treatment Among Adults Newly Insured Under the ACA
Objective: Approximately 25 million individuals are projected to gain insurance as a result of the Affordable Care Act (ACA). This study estimated the prevalence of behavioral health conditions and their treatment among individuals likely to gain...
The return on investment of postdischarge follow-up calls for suicidal ideation or deliberate self-harm.
Transitions of care are critical for individuals at risk of suicide. This study determined the return on investment (ROI) for providing postdischarge follow-up calls to patients at risk of suicide who are discharged from a hospital or an...
Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents
OBJECTIVE: Epoetin alfa (EPO) and darbepoetin alfa (DARB) are approved for the treatment of chemotherapy-related anemia (CRA) in patients with nonmyeloid malignancies. This study examined dosing and hematologic outcomes with these agents in...
Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls
Objectives: Estimate the productivity-related cost of depression in an employed population. Methods: By using administrative data, annual short-term disability (STD) and absenteeism costs ($2005) were compared for patients with depression and...
Recent trends in the financing of substance abuse treatment
OBJECTIVE: This article focuses on the implications of a recent study of substance abuse (SA) and mental health treatment expenditures for substance abuse treatment policy. Public and private expenditures for SA treatment are estimated and...
Mental Health and Substance Abuse Spending by Age, 2003
This article presents national estimates of mental health and substance abuse (MHSA) spending in 2003 by age groups. Overall, $121 billion was spent on MHSA treatment across all age groups in 2003. Of the total $100 billion spent on MH treatment...
Opioid medication discontinuation and risk of adverse opioid-related health care events
BACKGROUND: Between 2012 and 2017, the United States dramatically reduced opioid prescribing rates. While this may be appropriate given the opioid epidemic, there has been little research to guide the clinical practice of discontinuing patients...
An analysis of the slowdown in growth of spending for psychiatric drugs, 1986–2008
From 1993 to 2003, spending on medications was a major factor in unprecedented growth in mental health spending. An analysis of current trends shows that past high growth in spending on psychiatric drugs has slowed substantially—from an average...
Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001–2009
From 1986 to 2003, substance abuse spending covered by private insurance fell in nominal dollars from $2444 million to $2239 million. The present study updated this literature to determine recent spending and utilization trends and provides a...
Risk adjustment of capitation payments to behavioral health care carve-outs
This study used 1994-1995 administrative data from a large public employer to examine the viability of commercial risk adjustment systems for setting capitation payments to competing behavioral health care "carve-outs". The ability of...